Retiree Ray Flynn from Manchester, England, has been the first recipient of the Argus II implant, known as a ‘bionic eye’ which has restored some of the central vision he has been losing due to dry Age Related Macular Degeneration disease.
A pioneering vision procedure using advanced technology appears to have been a success in its inaugural trial.
Ray Flynn, an 80-year old from Manchester, England, is the first patient with dry Age Related Macular Degeneration, or AMD for short, to have been implanted with the Argus II device which the overseeing hospital has termed a “bionic eye.”
